Auriacombe M - Search Results

1

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J. Loustauneau A, et al. Among authors: auriacombe m. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Ann Med Interne (Paris). 2002. PMID: 12518080 Review. French.

2

Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders.

Chirokoff V, Dupuy M, Abdallah M, Fatseas M, Serre F, Auriacombe M, Misdrahi D, Berthoz S, Swendsen J, Sullivan EV, Chanraud S. Chirokoff V, et al. Among authors: auriacombe m. Addict Neurosci. 2023 Dec 15;9:100138. doi: 10.1016/j.addicn.2023.100138. Epub 2023 Nov 17. Addict Neurosci. 2023. PMID: 38389954 Free PMC article.

3

Transcranial electrical stimulation with high frequency intermittent current (Limoge's) potentiates opiate-induced analgesia: blind studies.

Stinus L, Auriacombe M, Tignol J, Limoge A, Le Moal M. Stinus L, et al. Among authors: auriacombe m. Pain. 1990 Sep;42(3):351-363. doi: 10.1016/0304-3959(90)91148-C. Pain. 1990. PMID: 2250924

4

[Substitution therapy in drug addictions].

Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J. Auriacombe M, et al. Rev Prat. 2003 Jun 15;53(12):1327-34. Rev Prat. 2003. PMID: 12920942 Review. French.

5

French field experience with buprenorphine.

Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. Auriacombe M, et al. Am J Addict. 2004;13 Suppl 1:S17-28. doi: 10.1080/10550490490440780. Am J Addict. 2004. PMID: 15204673

6

Social phobia and premature ejaculation: a case-control study.

Tignol J, Martin-Guehl C, Aouizerate B, Grabot D, Auriacombe M. Tignol J, et al. Among authors: auriacombe m. Depress Anxiety. 2006;23(3):153-7. doi: 10.1002/da.20159. Depress Anxiety. 2006. PMID: 16502416

7

[Benzodiazepine withdrawal in subjects on opiate substitution treatment].

Fatséas M, Lavie E, Denis C, Franques-Rénéric P, Tignol J, Auriacombe M. Fatséas M, et al. Among authors: auriacombe m. Presse Med. 2006 Apr;35(4 Pt 1):599-606. doi: 10.1016/s0755-4982(06)74647-4. Presse Med. 2006. PMID: 16614601 Review. French.

8

Why buprenorphine is so successful in treating opiate addiction in France.

Fatseas M, Auriacombe M. Fatseas M, et al. Among authors: auriacombe m. Curr Psychiatry Rep. 2007 Oct;9(5):358-64. doi: 10.1007/s11920-007-0046-2. Curr Psychiatry Rep. 2007. PMID: 17915074 Review.

9

Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.

Lavie E, Fatséas M, Daulouède JP, Denis C, Dubernet J, Cattan L, Auriacombe M. Lavie E, et al. Among authors: auriacombe m. Patient Prefer Adherence. 2008 Feb 2;2:369-78. doi: 10.2147/ppa.s4136. Patient Prefer Adherence. 2008. PMID: 19920984 Free PMC article.

10

Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.

Fatseas M, Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M. Fatseas M, et al. Among authors: auriacombe m. AIDS Behav. 2012 Oct;16(7):2082-90. doi: 10.1007/s10461-011-0054-4. AIDS Behav. 2012. PMID: 21983799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters